The role of surgery in the Zollinger-Ellison syndrome

J. C. Thompson, B. G. Lewis, I. Wiener, Courtney Townsend

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

When the Zollinger-Ellison syndrome was first identified, total gastrectomy was proposed as the most effective treatment for the secretory manifestations of the syndrome. Recently, however, great enthusiasm has developed for medical treatment by means of H2-receptor antagonists. The authors have cared for 27 patients with the Zollinger-Ellison syndrome at The University of Texas Medical Branch in the past 12 years and have been pleased with the results of total gastrectomy, which was performed in 23 of the 27 patients (one patient refused operation and three patients had lesser gastric operations). Twenty-three patients underwent total gastrectomy with Roux-en-Y esophagojejunostomy. There were no operative deaths. Primary tumors were found in 17 patients, seven of whom also had metastatic tumors. No tumors were found in nine patients. Nine patients are dead; the actuarial survival rate for all patients was 75% at 5 years and 52% at 10 years. Eleven of the 27 patients had the multiple endocrine neoplasia I syndrome. Of the 18 survivors, only three have normal serum gastrin levels, and all three had extrapancreatic gastrinomas, one in peripancreatic lymph nodes, one in the liver, and one in a cystic tumor attached to the stomach. Nutritional results were good to excellent, with a mean postoperative weight loss of 14.7% (mean follow-up period was 45 months). The authors conclude that treatment of the hypersecretory problems of the Zollinger-Ellison syndrome by total gastrectomy is safe and dependable. Results compare well with those of long-term medical management, whose success is dependent upon serial favorable responses to a lifetime of repeated challenges.

Original languageEnglish (US)
Pages (from-to)594-607
Number of pages14
JournalAnnals of Surgery
Volume197
Issue number5
StatePublished - 1983

Fingerprint

Zollinger-Ellison Syndrome
Gastrectomy
Neoplasms
Stomach
Gastrinoma
Multiple Endocrine Neoplasia
Histamine H2 Receptors
Gastrins
Survivors
Weight Loss
Therapeutics
Survival Rate
Lymph Nodes

ASJC Scopus subject areas

  • Surgery

Cite this

Thompson, J. C., Lewis, B. G., Wiener, I., & Townsend, C. (1983). The role of surgery in the Zollinger-Ellison syndrome. Annals of Surgery, 197(5), 594-607.

The role of surgery in the Zollinger-Ellison syndrome. / Thompson, J. C.; Lewis, B. G.; Wiener, I.; Townsend, Courtney.

In: Annals of Surgery, Vol. 197, No. 5, 1983, p. 594-607.

Research output: Contribution to journalArticle

Thompson, JC, Lewis, BG, Wiener, I & Townsend, C 1983, 'The role of surgery in the Zollinger-Ellison syndrome', Annals of Surgery, vol. 197, no. 5, pp. 594-607.
Thompson JC, Lewis BG, Wiener I, Townsend C. The role of surgery in the Zollinger-Ellison syndrome. Annals of Surgery. 1983;197(5):594-607.
Thompson, J. C. ; Lewis, B. G. ; Wiener, I. ; Townsend, Courtney. / The role of surgery in the Zollinger-Ellison syndrome. In: Annals of Surgery. 1983 ; Vol. 197, No. 5. pp. 594-607.
@article{e2a5c68bbac14e8f98e286f4fedab620,
title = "The role of surgery in the Zollinger-Ellison syndrome",
abstract = "When the Zollinger-Ellison syndrome was first identified, total gastrectomy was proposed as the most effective treatment for the secretory manifestations of the syndrome. Recently, however, great enthusiasm has developed for medical treatment by means of H2-receptor antagonists. The authors have cared for 27 patients with the Zollinger-Ellison syndrome at The University of Texas Medical Branch in the past 12 years and have been pleased with the results of total gastrectomy, which was performed in 23 of the 27 patients (one patient refused operation and three patients had lesser gastric operations). Twenty-three patients underwent total gastrectomy with Roux-en-Y esophagojejunostomy. There were no operative deaths. Primary tumors were found in 17 patients, seven of whom also had metastatic tumors. No tumors were found in nine patients. Nine patients are dead; the actuarial survival rate for all patients was 75{\%} at 5 years and 52{\%} at 10 years. Eleven of the 27 patients had the multiple endocrine neoplasia I syndrome. Of the 18 survivors, only three have normal serum gastrin levels, and all three had extrapancreatic gastrinomas, one in peripancreatic lymph nodes, one in the liver, and one in a cystic tumor attached to the stomach. Nutritional results were good to excellent, with a mean postoperative weight loss of 14.7{\%} (mean follow-up period was 45 months). The authors conclude that treatment of the hypersecretory problems of the Zollinger-Ellison syndrome by total gastrectomy is safe and dependable. Results compare well with those of long-term medical management, whose success is dependent upon serial favorable responses to a lifetime of repeated challenges.",
author = "Thompson, {J. C.} and Lewis, {B. G.} and I. Wiener and Courtney Townsend",
year = "1983",
language = "English (US)",
volume = "197",
pages = "594--607",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - The role of surgery in the Zollinger-Ellison syndrome

AU - Thompson, J. C.

AU - Lewis, B. G.

AU - Wiener, I.

AU - Townsend, Courtney

PY - 1983

Y1 - 1983

N2 - When the Zollinger-Ellison syndrome was first identified, total gastrectomy was proposed as the most effective treatment for the secretory manifestations of the syndrome. Recently, however, great enthusiasm has developed for medical treatment by means of H2-receptor antagonists. The authors have cared for 27 patients with the Zollinger-Ellison syndrome at The University of Texas Medical Branch in the past 12 years and have been pleased with the results of total gastrectomy, which was performed in 23 of the 27 patients (one patient refused operation and three patients had lesser gastric operations). Twenty-three patients underwent total gastrectomy with Roux-en-Y esophagojejunostomy. There were no operative deaths. Primary tumors were found in 17 patients, seven of whom also had metastatic tumors. No tumors were found in nine patients. Nine patients are dead; the actuarial survival rate for all patients was 75% at 5 years and 52% at 10 years. Eleven of the 27 patients had the multiple endocrine neoplasia I syndrome. Of the 18 survivors, only three have normal serum gastrin levels, and all three had extrapancreatic gastrinomas, one in peripancreatic lymph nodes, one in the liver, and one in a cystic tumor attached to the stomach. Nutritional results were good to excellent, with a mean postoperative weight loss of 14.7% (mean follow-up period was 45 months). The authors conclude that treatment of the hypersecretory problems of the Zollinger-Ellison syndrome by total gastrectomy is safe and dependable. Results compare well with those of long-term medical management, whose success is dependent upon serial favorable responses to a lifetime of repeated challenges.

AB - When the Zollinger-Ellison syndrome was first identified, total gastrectomy was proposed as the most effective treatment for the secretory manifestations of the syndrome. Recently, however, great enthusiasm has developed for medical treatment by means of H2-receptor antagonists. The authors have cared for 27 patients with the Zollinger-Ellison syndrome at The University of Texas Medical Branch in the past 12 years and have been pleased with the results of total gastrectomy, which was performed in 23 of the 27 patients (one patient refused operation and three patients had lesser gastric operations). Twenty-three patients underwent total gastrectomy with Roux-en-Y esophagojejunostomy. There were no operative deaths. Primary tumors were found in 17 patients, seven of whom also had metastatic tumors. No tumors were found in nine patients. Nine patients are dead; the actuarial survival rate for all patients was 75% at 5 years and 52% at 10 years. Eleven of the 27 patients had the multiple endocrine neoplasia I syndrome. Of the 18 survivors, only three have normal serum gastrin levels, and all three had extrapancreatic gastrinomas, one in peripancreatic lymph nodes, one in the liver, and one in a cystic tumor attached to the stomach. Nutritional results were good to excellent, with a mean postoperative weight loss of 14.7% (mean follow-up period was 45 months). The authors conclude that treatment of the hypersecretory problems of the Zollinger-Ellison syndrome by total gastrectomy is safe and dependable. Results compare well with those of long-term medical management, whose success is dependent upon serial favorable responses to a lifetime of repeated challenges.

UR - http://www.scopus.com/inward/record.url?scp=0020535052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020535052&partnerID=8YFLogxK

M3 - Article

C2 - 6847279

AN - SCOPUS:0020535052

VL - 197

SP - 594

EP - 607

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 5

ER -